Sale
Biotinylated Human BTN3A2 Protein (BNT-HM4A2B)
$472.50 – $1,575.00
KACTUS Biosystems Biotinylated Human BTN3A2 Protein (BNT-HM4A2B) (catalog No. BNT-HM4A2B) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln30-Trp248.
- Details & Specifications
- References
- More Offers
| Catalog No. | BNT-HM4A2B |
|---|---|
| Product Name | Biotinylated Human BTN3A2 Protein (BNT-HM4A2B) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Species | Human |
| Source | HEK293 |
| Accession | P78410-1 |
| Product Tag | C-His-Avi |
| Biotinylated | yes |
| Exact Sequence | Gln30-Trp248 |
| Molecular Weight | The protein has a predicted MW of 26.5 kDa. Due to glycosylation, the protein migrates to 30-38 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 93% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
BNT-HM4A2B: Biotinylated Human BTN3A2 Protein (BNT-HM4A2B)
BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.
Please remember our product information: Biotinylated Human BTN3A2 Protein (BNT-HM4A2B) catalog number: BNT-HM4A2B KACTUS Biosystems
No more offers for this product!